Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Clinical Impact of Immunogenicity and Predictive Tools

16th July 2014, London, United Kingdom

Overview of the Workshop

Open/Close

This workshop will focus on the clinical impacts of immunogenicity on safety and efficacy with the example cases. In addition. Immunogenicity strategies during clinical stages will be discussed including the risk-assessment of biologics. A short intro in bioassays and the importance to measure neutralizing antibodies will be presented. Last, but not least current overview of predictive immunogenicity tools will be given and the question, “What translational value do the data from preclinics have to the clinical situation” will be discussed.

Why you should attend

Open/Close

About the Workshop Leader

Open/Close

About the Organisation

Open/Close